TRCT
NVNO

Tower Research Capital (TRC)’s enVVeno Medical NVNO Stock Holding History

Tower Research Capital (TRC)’s Portfolio NVNO Stock Details NVNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.49K Buy
+542
New +$5.93K ﹤0.01% 4113
2025
Q3 		– Sell
-17
Closed -$2.36K – 5487
2025
Q2 		$2.36K Sell
17
-29
-63% -$3.43K ﹤0.01% 4661
2025
Q1 		$4.22K Sell
46
-147
-76% -$16.4K ﹤0.01% 4286
2024
Q4 		$20.4K Buy
193
+169
+704% +$18.9K ﹤0.01% 3169
2024
Q3 		$2.87K Sell
24
-44
-65% -$8.08K ﹤0.01% 4931
2024
Q2 		$12.5K Sell
68
-32
-32% -$5.59K ﹤0.01% 4024
2024
Q1 		$19K Buy
100
+19
+23% +$3.41K ﹤0.01% 3050
2023
Q4 		$14.6K Buy
81
+80
+8,000% +$12.7K ﹤0.01% 3869
2023
Q3 		$113 Sell
1
-91
-99% -$15.2K ﹤0.01% 5716
2023
Q2 		$9.93K Buy
92
+47
+104% +$6.1K ﹤0.01% 4196
2023
Q1 		$7K Sell
45
-8
-15% -$1.5K ﹤0.01% 4758
2022
Q4 		$9K Sell
53
-23
-30% -$4.67K ﹤0.01% 4226
2022
Q3 		$17K Buy
76
+61
+407% +$13K ﹤0.01% 4077
2022
Q2 		$2K Buy
15
+6
+67% +$931 ﹤0.01% 5575
2022
Q1 		$2K Sell
9
-13
-59% -$2.52K ﹤0.01% 5576
2021
Q4 		$5K Buy
+22
New +$6.2K ﹤0.01% 5174
2021
Q3 		– Sell
-5
Closed -$1K – 6042
2021
Q2 		$1K Sell
5
-12
-71% -$2.58K ﹤0.01% 5226
2021
Q1 		$4K Buy
17
+14
+467% +$3.9K ﹤0.01% 4800
2020
Q4 		$1K Buy
+3
New +$931 ﹤0.01% 5020
2018
Q4 		– Sell
-1
Closed -$2K – 4188
2018
Q3 		$2K Buy
+1
New +$2.31K ﹤0.01% 3456

Other funds holding NVNO

KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Tower Research Capital (TRC)'s NVNO Position: Q1 2026 in Review

Tower Research Capital (TRC) opened a new position in enVVeno Medical (NVNO) in Q1 2026: 542 shares worth $5.49K. The stake represents ﹤0.01% of the portfolio and ranks #4113 among its holdings. This is a return to the name: Tower Research Capital (TRC) previously reported a position in NVNO as recently as Q2 2025.

Tower Research Capital (TRC) first reported a position in NVNO in Q3 2018 and has held it in 20 quarters since. The position peaked at $20.4K in Q4 2024. 17 funds tracked by Wall St. Rank hold NVNO as of Q1 2026.

  • Tower Research Capital (TRC) held 542 shares of enVVeno Medical worth $5.49K as of Q1 2026.
  • enVVeno Medical was a new Tower Research Capital (TRC) position in Q1 2026.
  • enVVeno Medical made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #4113 holding.
  • Tower Research Capital (TRC) first reported a position in enVVeno Medical in Q3 2018 and has held it in 20 quarters since.
  • Tower Research Capital (TRC)'s enVVeno Medical position peaked at $20.4K in Q4 2024.
  • 17 funds tracked by Wall St. Rank held enVVeno Medical as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.